Victhom announces the establishment of a Clinical Advisory Board



    QUEBEC, Feb. 18 /CNW Telbec/ - Victhom Human Bionics Inc., "Victhom"
(TSX: VHB), announced today that it has held its first Clinical Advisory Board
("CAB") meeting in Montreal, Canada on February 13. The CAB consists of
representatives from multiple medical specialties, including physiatry,
neurology and neurosurgery. The CAB's primary objective is to provide
professional expertise and guidance to the Company as it continues to invest
in clinical activities for its implantable neurostimulation devices for the
treatment of gait disorders. Mr. Nader Kameli, Chief Operating Officer of
Victhom's Neurobionix division, commented: "We are delighted to be working
with a group of clinicians who are so preeminent in their respective fields.
We look forward to engaging them frequently as we continue to build upon our
product portfolio designed to treat gait disorders".

    The current members of the CAB include:

    John Chae, M.D.

    Dr. Chae is Associate Professor of Physical Medicine and Rehabilitation
(PM&R) and Biomedical Engineering at Case Western Reserve University. He
received his Bachelor of Science and Master's in Engineering from Duke
University and Dartmouth College, respectively. He received his MD from the
New Jersey Medical School and clinical training in PM&R from Kessler Institute
for Rehabilitation of the New Jersey Medical School. He completed the
Rehabilitation Medicine Scientist Training Program Fellowship at Case Western
Reserve University. He is Director of Research for the Department of PM&R and
Associate Director of Clinical Affairs for the Cleveland Functional Electrical
Stimulation (FES) Center. His research is funded by the NIH and focuses on the
application of FES for neuroprostheses, neural plasticity and shoulder
dysfunction in hemiplegia.

    Alberto Esquenazi, M.D.

    Dr. Esquenazi is Chairman and Professor at the Department of Physical
Medicine and Rehabilitation at MossRehab, which is part of the Albert Einstein
Healthcare Network. He also holds appointments as the Director, Gait and
Motion Analysis Laboratory, Clinical Director, Regional Amputee Center, Chief,
Prosthetics and Orthotic Clinic. He is board-certified in physical medicine
and rehabilitation and a member of the Task Force on Medical Rehabilitation
Research for the U.S. Department of Health and Human Services. Dr. Esquenazi
received his medical degree at the National Autonomous University of Mexico
School of Medicine in Mexico City. He served his residency at Temple
University School of Medicine. He is a Fellow of the American Academy of
Cerebral Palsy and Developmental Medicine, the International Society for
Prosthetics/Orthotics and a Charter Member of the North American Society of
Gait and Clinical Movement Analysis.

    Brian Kopell, M.D.

    Dr. Kopell is currently Assistant Professor of Neurosurgery at the
Medical College of Wisconsin, where he specializes in the neuromodulation and
functional neurosurgical treatment of various functional neurological maladies
such as movement, pain and psychiatric disorders. Dr. Kopell holds an M.D.
from the New York University School of Medicine, where he also completed his
residency. Dr. Kopell's fellowships were completed at the University Hospital
in Zurich, Cleveland Clinic Foundation and University Hospital in Ankara. Dr.
Kopell's special research interests include new applications of
neurostimulation technologies and functional imaging.

    Michael O'Dell, M.D.

    Dr. O'Dell is the Chief of Clinical Services, Department of
Rehabilitation Medicine at New York-Presbyterian Hospital, Weill Cornell
Center and Professor of Clinical Rehabilitation Medicine at Weill Cornell
Medical College. He received his medical degree from Indiana University School
of Medicine, his residency in PMR at the Hospital of University of
Pennsylvania, and completed his fellowship in Brain Injury and Trauma at
Mediplex-Rehab in Camden, New Jersey. Dr. O'Dell is nationally known for his
clinical expertise, education and research in the area of neurological
rehabilitation.

    Kanakadurga R. Poduri, M.D.

    Dr. Poduri is an Associate Professor and Chair of the Department of
Physical Medicine and Rehabilitation at the University of Rochester School of
Medicine and Dentistry. Currently, Dr. Poduri serves as the Medical Director
of PM&R services at the Strong Memorial Hospital in Rochester, NY. She is also
the Program Director for the PM&R residency program at the University of
Rochester. She graduated from Karnatak Medical College in Hubli, India,
received her M.D. degree from the Board or Regents of the University of
Rochester and completed her residency training at the University of Rochester,
where she is also a Fellowship trained in Geriatric Rehabilitation. Dr. Poduri
is a diplomat of the American Board of Physical Medicine and Rehabilitation,
American Academy of Pain Management and she is Subspecialty certified in
Spinal Cord Injury Medicine. Her research work presentations and publications
are in the areas of stroke, brain injury, spinal cord, amputations and
hypertension.

    Richard Zorowitz, M.D.

    Dr. Zorowitz is the Chief, Department of Physical Medicine and
Rehabilitation, Johns Hopkins Bayview Medical Center as well as Associate
Professor of Physical Medicine and Rehabilitation at the Johns Hopkins
University School of Medicine. Dr. Zorowitz earned his medical degree at
Tulane University and completed his residency at the Rehabilitation Institute
of Chicago, Northwestern University. He is a member of the American Academy of
Physical Medicine and Rehabilitation (AAPM&R). Among his appointments, Dr.
Zorowitz serves as Chairman of the Rehabilitation and Recovery Advisory Board
and Professional Advisory Committee of the National Stroke Association and
Co-Chairman of the Standing Scientific Committee on stroke rehabilitation of
the American Stroke Association. His research interests include stroke
rehabilitation outcomes, dysphagia, spasticity and the hemiplegic shoulder.

    Frank Silver, M.D.

    Dr. Silver is a Professor of Medicine in the Division of Neurology at the
University of Toronto. He graduated from the Faculty of Medicine at the
University of Toronto in 1978 and completed a Neurology residency in Toronto
in 1983. After a two-year fellowship at the Cerebrovascular Research Centre at
the University of Pennsylvania, in Philadelphia, Dr. Silver returned to
Toronto to be on staff at the Toronto General Hospital. Dr. Silver is
currently the Director of the University Health Network's Stroke Program and
the Medical Director of the Toronto West Stroke Region. Dr. Silver's academic
interests are in the areas of stroke management and improving stroke care
delivery through regional organized care. He has been involved in the
implementation and monitoring of many clinical trials in stroke. He is
currently on the board of the Canadian Stroke Consortium. Dr. Silver was a
past theme leader in the Canadian Stroke Network. He is a co-principal
investigator of the Registry of the Canadian Stroke Network and founded
Ontario's Telestroke program.

    For a complete biography of the CAB members, go to
http://www.victhom.com/en/neurostimulation/clinical-advisory-board.php

    About Victhom

    Victhom discovers, develops and manufactures bionic devices involved in
the treatment of a variety of physical and physiological dysfunctions.
Victhom's Neurobionix division focuses on the development and
commercialization of technologies and products involving implantable devices
that feature neurosensing and neurostimulation components, integrated with
artificial intelligence. Victhom's Biotronix division develops biomechatronic
products to support or replace peripheral limbs in what is known as the
orthotics and prosthetics market.

    FORWARD-LOOKING STATEMENTS

    Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and other
factors that may cause Victhom's actual results, performance or achievements
to be materially different from those expressed or implied by any of Victhom's
statements. Actual events or results may differ materially. We disclaim any
intention, and assume no obligation, to update these forward-looking
statements.




For further information:

For further information: Nader Kameli, Chief Operating Officer,
Neurobionix division, Victhom Human Bionics Inc., (418) 872-5665, Fax: (418)
872-6926, nader.kameli@victhom.com; www.victhom.com; Source: Victhom Human
Bionics Inc.

Organization Profile

Victhom Human Bionics Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890